About Lazuline Biotech Private Limited
Data last updated:
Lazuline Biotech Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Mcc Consulting Private Limited. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 24 October 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC118015. Its GSTIN is 36AAECT0136D1ZT (Telangana).
The company has an authorised share capital of ₹54 Cr and a paid-up capital of ₹42.14 Cr. It was formerly known as Tkr Lifesciences Private Limited. It is led by directors including Kumar Venkata Naga Prasad Kandimalla (Managing Director) and Ramireddy Kodanda Tummuru.
Its last annual general meeting (AGM) was held on 30 December 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹10.42 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹15.93 Cr (net margin -152.9%) and EBITDA of ₹1.28 Cr (EBITDA margin 12.3%).
The company has about 56 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Lazuline Bio. As per MCA filings, the company has open charges of ₹71 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it; 3 cases are pending. The company has 52 deals on record (31 funding rounds, 20 secondary share transfers, 1 rights issue), with disclosed funding of ₹100.95 Cr; the latest was in August 2022. The company has 4 MSME Form 1 returns on record between 2019 and 2021, listing 49 overdue payments to 22 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lazulinebio.com.
Company details
CIN history
Lazuline Biotech has one previous CIN (Corporate Identification Number): U24232AP2011PTC077135. The current CIN is U24232TG2011PTC118015, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC118015 | Current |
| U24232AP2011PTC077135 | Previous |
Contact details
Lazuline Biotech Private Limited's registered office is in Hyderabad, Telangana. Its website is lazulinebio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No 769 M.No 8 – 2 – 293/82/A/769/1 3rd Floor Beside Iqbalia International School, Road No 44, Hyderabad, Telangana, India – 500033
- IndustryLife Sciences, Biotechnology
To see the full contact details of Lazuline Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Lazuline Biotech operates one associated brand: Lazuline Bio. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Small molecules and biosimilars are developed for disease treatments. | lazulinebio.com |
Business activity
The main business activity of Lazuline Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lazuline Biotech Private Limited, buy the company report.
Financials of Lazuline Biotech Private Limited
FY 2023 filings availableLazuline Biotech Private Limited reported revenue of ₹10.42 Cr (up 181% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 181% in the latest year. EBITDA rose 132% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.28 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹15.93 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.3% | ||||
| Net Profit Margin | -152.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lazuline Biotech Private Limited, buy the company report.
Board of directors of Lazuline Biotech Private Limited
Lazuline Biotech has 3 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramireddy Kodanda Tummuru | Director | 22 Apr 2017 | 9 Years 6 Months | Current |
| Satya Latha Kandimalla | Director | 21 Jul 2017 | 9 Years 3 Months | Current |
| Kumar Venkata Naga Prasad Kandimalla Also directs: Riddhi Proven Private Limited, KNP Projects Private Limited, MCC Consulting Private Limited and 2 more | Managing Director | 01 Mar 2019 | 7 Years 8 Months | Current |
Auditor
Lazuline Biotech Private Limited is audited by BALAJINAIDU & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BALAJINAIDU & CO | FY 2022 | 006676S |
Shareholding
The shareholding of Lazuline Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lazuline Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Nov 2021 | 100516803 | Others | ₹2.9 Cr | Open | |
| 30 Jun 2021 | 100460692 | Canara Bank | ₹12 Cr | Open | |
| 27 Oct 2020 | 100400506 | Canara Bank | ₹4.15 Cr | Open | |
| 05 Jan 2019 | 100234407 | Canara Bank | ₹51.95 Cr | Open |
To see the full charge records of Lazuline Biotech Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Lazuline Biotech Private Limited has 52 deals on record (31 funding rounds, 20 secondary share transfers, 1 rights issue), with disclosed funding of ₹100.95 Cr; the latest was in August 2022.
Deals on record (5 of 52)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2022 | Funding round | ₹27 Lakh | Investors: MCC Consulting Private Limited |
| Mar 2022 | Funding round | ₹5 Lakh | Investors: MCC Consulting Private Limited |
| Feb 2022 | Funding round | ₹3 Cr | Investors: Izeal Info Solutions Private Limited , 3 individuals |
| Feb 2022 | Funding round | ₹14 Lakh | Investors: MCC Consulting Private Limited |
| Feb 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: MCC Consulting Private Limited |
To see the full deal history of Lazuline Biotech Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Lazuline Biotech Private Limited has 5 court cases on record: 1 filed by Lazuline Biotech, 4 filed against it. 3 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 2 |
| High courts | 1 | 1 | 1 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed against the company by M/S.National Scientific Proiducts, Rep.By Smt.J.Latha Kali Matha | Pending |
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company by an individual | Pending |
| High Court | Appeal | Filed against the company by an individual | Pending |
| NCLT, Hyderabad | Insolvency matter | Filed by the company against Union Bank of India and 1 other | Disposed |
| District court, BENGALURU, Karnataka | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of Lazuline Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Lazuline Biotech Private Limited has 4 MSME Form 1 returns on record between 2019 and 2021, listing 49 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Agilent Technologies India Pvt Ltd | |||
| Cleansep Systems Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Lazuline Biotech Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Lazuline Biotech Private Limited has a workforce of 56 employees on its EPFO records as of Jun 2023, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2023-24 | 56 |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Lazuline Biotech Private Limited, buy the company report.
GST
Lazuline Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECT0136D1ZT | Telangana | Active | 01 Aug 2017 |
To see the full GST registrations and return filing status of Lazuline Biotech Private Limited, buy the company report.
Recent activity
Lazuline Biotech Private Limited has 14 board changes on record since 2014: 3 appointments and 11 cessations. The latest: Palla Sivaiah ceased to be Company Secretary on 01 May 2024.
13 earlier events are in the company report.
Frequently asked questions
Lazuline Biotech is an active private limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 24 October 2011 (15+ years old) and is registered under CIN U24232TG2011PTC118015.
Lazuline Biotech has 3 current directors:
- Kumar Venkata Naga Prasad Kandimalla - Managing Director
- Ramireddy Kodanda Tummuru - Director
- Satya Latha Kandimalla - Director
The latest financial statements of Lazuline Biotech on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 December 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Lazuline Biotech is 36AAECT0136D1ZT, registered in Telangana.
The CIN (Corporate Identification Number) of Lazuline Biotech is U24232TG2011PTC118015. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lazuline Biotech has 5 court cases on record: 1 filed by the company and 4 filed against it. 3 are pending. Most are in the district courts.
Lazuline Biotech was incorporated on 24 October 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
Lazuline Biotech has 52 deals on record (31 funding rounds, 20 secondary share transfers, 1 rights issue), with disclosed funding of ₹100.95 Cr; the latest was in August 2022.
Palla Sivaiah ceased to be Company Secretary on 01 May 2024. Kumar Venkata Naga Prasad Kandimalla was appointed as Managing Director on 01 Mar 2019. Kumar Venkata Naga Prasad Kandimalla ceased to be Director on 01 Mar 2019. Lazuline Biotech has 14 board changes on record in total.
Lazuline Biotech has 4 MSME Form 1 returns on record between 2019 and 2021, listing 49 overdue payments to 22 micro and small suppliers. The latest return was filed on 13 May 2021.
Lazuline Biotech can be reached through the website lazulinebio.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
